Macrophages could be a key target cell for rhCC16 given the important contributions of macrophages to CS-induced inflammation and emphysema development and the known activities of CC16 and NF-κB in inhibiting and increasing macrophage activation, respectively (39). The gene discussed is NFKB1; the disease is pulmonary emphysema.